Deutsch | English | Français - CHF | EUR | USD
Analysen | Arzt | Interaktionen | Medikamente | MiGel | Services | Spital | Zulassungsinhaber
Sie befinden sich in - Neuregistrierungen - Fachinformation zu Emend 80 mg
Fachinformation zu Emend®:Merck Sharp & Dohme Chibret AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info.
A04AD12 - AprepitantATC-DDD Version 2007. Source: WHO
A04A - ANTIEMETICS AND ANTINAUSEANTS

Antihistamines, which are often used as antiemetics, are classified in R06 - Antihistamines for systemic use.
Metoclopramide is classified in A03FA.
Combinations with analgesics are classified in N02 - Analgesics.
Antivertigo preparations, see N07C.

A04AD - Other antiemetics

The DDD for scopolamine plaster is one plaster (i.e. 1 UD). This DDD is based on prophylaxis of motion sickness.
DDDs for other substances classified in this group are based on antiemetic treatment.
The DDD for aprepitant is the average daily dose during a three days course.

A04AD12 - Aprepitant
StärkeAdm.RouteNote
O
O
LGPL2009 ywesee.com, Commit-ID
Hilfe | FAQ | Anmeldung | Kontakt | Home